Organism name | Tournefortia sarmentosa |
---|---|
Genus | Tournefortia |
Family | Heliotropiaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Tournefortia |
---|---|
Linked NCBI taxonomy ID | 79403 |
Linked level | genus |
Family in NCBI taxonomy | Boraginaceae |
---|---|
ID | 21571 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00002121
![]() |
Supinine
|
No. 308 | No. 2 |
![]() |
||||
C00002400
![]() |
Lithospermic acid
/ Lithosperminc acid |
CHEMBL518243
|
C046833
|
0 / 2 | No. 494 |
![]() |
||
C00037345
![]() |
Isosalvianolic acid C
|
CHEMBL464633
|
No. 494 |
![]() |
||||
C00002772
![]() |
Salvianolic acid A
|
CHEMBL457077
|
C066201
|
5 / 5 / 7 | 0 / 3 | No. 494 |
![]() |
|
C00002770
![]() |
Rosmarinic acid
|
CHEMBL66966
CHEMBL324842 CHEMBL1315100 CHEMBL2111558 |
48 / 35 / 38 | No. 749 |
![]() |
|||
C00000206
![]() |
Saligel
/ Salonil / Salicylic acid / 2-Carboxyphenol / o-Hydroxybenzoic acid |
CHEMBL424
|
D020156
|
124 / 50 / 42 | 15 / 12 | No. 817 | No. 81 |
![]() |
C00037776
![]() |
Salvianolic acid F
|
CHEMBL464884
|
No. 1951 |
![]() |
||||
C00046468
![]() |
Tournefolic acid A
|
CHEMBL465836
|
No. 3850 |
![]() |
||||
C00046467
![]() |
Tournefolal
|
No. 3850 |
![]() |
|||||
C00046469
![]() |
Tournefolic acid B
|
CHEMBL464650
|
No. 3850 |
![]() |
||||
C00049754
![]() |
Tournefolin C
|
No. 5114 |
![]() |
|||||
C00049753
![]() |
Tournefolin B
|
No. 5114 |
![]() |
|||||
C00046470
![]() |
Tournefolic acid B ethyl ester
|
CHEMBL515985
|
No. 5934 |
![]() |
||||
C00049752
![]() |
Tournefolin A
/ (-)-Tournefolin A |
No. 8185 |
![]() |
|||||
C00007468
![]() |
Allantoin
|
CHEMBL593429
CHEMBL1230080 |
D000481
|
12 / 12 / 14 | No. 8950 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000206 C00002770 C00007468 | 1 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000206 C00002770 C00007468 | 0 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000206 C00002770 C00007468 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000206 C00002770 C00007468 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000206 C00002770 C00007468 | 0 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000206 C00002770 C00002772 | 0 / 1 |
P51692 | Signal transducer and activator of transcription 5B | Unclassified protein | C00002770 C00002772 | 1 / 1 |
P42224 | Signal transducer and activator of transcription 1-alpha/beta | Unclassified protein | C00002770 C00002772 | 3 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000206 C00002770 | 2 / 2 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000206 C00002770 | 0 / 3 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000206 C00002770 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002770 C00007468 | 0 / 1 |
P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | C00002770 C00002772 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002770 C00007468 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00000206 C00002770 | 0 / 1 |
P40763 | Signal transducer and activator of transcription 3 | Transcription Factor | C00002770 C00002772 | 1 / 2 |
P15121 | Aldose reductase | Enzyme | C00000206 C00002770 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00000206 C00002770 | 0 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000206 C00002770 | 0 / 0 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002770 C00007468 | 1 / 4 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00000206 C00002770 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000206 | 0 / 0 |
P22894 | Neutrophil collagenase | M10A | C00000206 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00000206 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000206 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00000206 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000206 | 2 / 2 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00002770 | 0 / 0 |
O14924 | Regulator of G-protein signaling 12 | Unclassified protein | C00007468 | 0 / 0 |
P37840 | Alpha-synuclein | Unclassified protein | C00007468 | 4 / 2 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00007468 | 3 / 2 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00002770 | 3 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000206 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000206 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000206 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00000206 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00000206 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000206 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000206 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000206 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000206 | 0 / 0 |
P02768 | Serum albumin | Secreted protein | C00000206 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00000206 | 1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000206 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00000206 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000206 | 0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00000206 | 0 / 0 |
P08236 | Beta-glucuronidase | Enzyme | C00000206 | 1 / 2 |
P54132 | Bloom syndrome protein | Enzyme | C00002770 | 1 / 2 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00002770 | 1 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000206 | 1 / 8 |
P11473 | Vitamin D3 receptor | NR1I1 | C00007468 | 2 / 3 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00000206 | 2 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002770 | 1 / 1 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000206 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000206 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000206 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00000206 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00000206 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000206 | 0 / 0 |
P05067 | Amyloid beta A4 protein | Membrane receptor | C00000206 | 2 / 2 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000206 | 1 / 1 |
O14920 | Inhibitor of nuclear factor kappa-B kinase subunit beta | Other serine/threonine protein kinase | C00000206 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000206 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000206 | 1 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00000206 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000206 | 0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | C00000206 | 1 / 2 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000206 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00002770 | 0 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00002770 | 6 / 4 |
O75496 | Geminin | Unclassified protein | C00000206 | 0 / 0 |
Q8TCC7 | Solute carrier family 22 member 8 | Antiporter | C00000206 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00000206 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000206 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000206 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00000206 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00000206 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00000206 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000206 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000206 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000206 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000206 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00000206 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000206 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000206 | 1 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00000206 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000206 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00000206 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000206 | 1 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00002770 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000206 | 0 / 0 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000206 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00002770 | 1 / 1 |
Q4U2R8 | Solute carrier family 22 member 6 | Antiporter | C00000206 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002770 | 0 / 0 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00002770 | 3 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000206 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000206 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000206 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000206 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000206 | 2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000206 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000206 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00000206 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000206 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000206 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000206 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000206 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000206 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000206 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000206 | 2 / 1 |
P08246 | Neutrophil elastase | S1A | C00000206 | 2 / 1 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00000206 | 0 / 1 |
P08253 | 72 kDa type IV collagenase | M10A | C00000206 | 1 / 3 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002770 | 3 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000206 | 2 / 2 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000206 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002770 | 0 / 0 |
P06133 | UDP-glucuronosyltransferase 2B4 | Enzyme | C00000206 | 0 / 0 |
P36537 | UDP-glucuronosyltransferase 2B10 | Enzyme | C00000206 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00000206 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000206 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000206 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00000206 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000206 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000206 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000206 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000206 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00000206 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00000206 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000206 | 0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00000206 | 0 / 0 |
P14618 | Pyruvate kinase PKM | Enzyme | C00002770 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000206 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00002770 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00002770 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002770 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00002770 | 4 / 3 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000206 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000206 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00000206 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000206 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000206 | 1 / 1 |
P07451 | Carbonic anhydrase 3 | Lyase | C00000206 | 0 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00000206 | 0 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000206 | 0 / 0 |
P08254 | Stromelysin-1 | M10A | C00000206 | 1 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00000206 | 1 / 1 |
Q12794 | Hyaluronidase-1 | Enzyme | C00002770 | 1 / 2 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00002770 | 0 / 0 |
Q9UHC3 | Acid-sensing ion channel 3 | Unclassified protein | C00000206 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00002770 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00002770 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00000206 | 4 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002770 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002770 | 1 / 1 |
Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | C00002770 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00000206 | 0 / 0 |
Q9NSA0 | Solute carrier family 22 member 11 | Transporter | C00000206 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002770 | 0 / 0 |
Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00002770 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00000206
|
1646 | AKR1C2, AKR1C-pseudo, BABP, DD, DD2, DDH2, HAKRD, HBAB, MCDR2, SRXY8 | aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) |
C00000206
|
8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00000206
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00000206
|
23764 | MAFF, U-MAF, hMafF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
C00000206
|
4489 | MT1A, MT1, MT1S, MTC | metallothionein 1A |
C00000206
|
55867 | SLC22A11, OAT4, hOAT4 | solute carrier family 22 (organic anion/urate transporter), member 11 |
C00000206
|
9356 | SLC22A6, HOAT1, OAT1, PAHT, ROAT1 | solute carrier family 22 (organic anion transporter), member 6 |
C00000206
|
10864 | SLC22A7, NLT, OAT2 | solute carrier family 22 (organic anion transporter), member 7 |
C00000206
|
114571 | SLC22A9, HOAT4, OAT4, OAT7, UST3H, ust3 | solute carrier family 22 (organic anion transporter), member 9 |
C00000206
|
7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00000206
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00000206
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00000206
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00000206
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00000206
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#104300 | Alzheimer disease; ad |
P05067
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#600807 | Asthma, susceptibility to |
Q13093
|
#209950 | Atypical mycobacteriosis, familial |
P42224
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#614162 | Candidiasis, familial, 7; candf7 |
P42224
|
#605714 | Cerebral amyloid angiopathy, app-related |
P05067
|
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#162800 | Cyclic neutropenia |
P08246
|
#127750 | Dementia, lewy body; dlb |
P37840
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#232300 | Glycogen storage disease ii |
P10253
|
#245590 | Growth hormone insensitivity with immunodeficiency |
P51692
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#147060 | Hyper-ige recurrent infection syndrome, autosomal dominant |
P40763
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#601492 | Mucopolysaccharidosis, type ix; mps9 |
Q12794
|
#253220 | Mucopolysaccharidosis, type vii; mps7 |
P08236
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613796 | Mycobacterial and viral infections, susceptibility to, autosomal recessive |
P42224
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
#605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
#168600 | Parkinson disease, late-onset; pd |
P04062
P37840 |
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#607276 | Resting heart rate, variation in |
P08588
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P40763 (related) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P08253 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
P37840 (related) |
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00056 | Alzheimer's disease (AD) |
P05067
(related)
|
H01185 | Cerebral amyloid angiopathy (CAA) |
P05067
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00132 | Mucopolysaccharidosis type VII (MPS7) |
P08236
(related)
|
H00421 | Mucopolysaccharidosis (MPS) |
P08236
(related)
Q12794 (related) |
H00100 | Neutropenic disorders |
P08246
(related)
|
H00025 | Penile cancer |
P08253
(related)
P14780 (related) P35354 (related) |
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00057 | Parkinson's disease (PD) |
P37840
(related)
|
H00107 | Other well-defined immunodeficiency syndromes |
P40763
(related)
|
H00089 | IFN-gamma/IL-12 axis |
P42224
(related)
|
H00363 | Candidiasis |
P42224
(related)
|
H01109 | Chronic mucocutaneous candidiasis (CMC) |
P42224
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00931 | Growth hormone insensitivity with immunodeficiency |
P51692
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00133 | Mucopolysaccharidosis type IX (MPS9) |
Q12794
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D015210 | Arthritis, Gouty |
C00002400
|
D007249 | Inflammation |
C00002400
|
D020324 | Amnesia, Anterograde |
C00002772
|
D008107 | Liver Diseases |
C00002772
|
D009203 | Myocardial Infarction |
C00002772
|
D001249 | Asthma |
C00000206
|
D003128 | COMA |
C00000206
|
D004342 | Drug Hypersensitivity |
C00000206
|
D034381 | Hearing Loss |
C00000206
|
D006685 | Hoarseness |
C00000206
|
D007819 | Laryngeal Edema |
C00000206
|
D009668 | Nose Diseases |
C00000206
|
D049188 | Prenatal Injuries |
C00000206
|
D012640 | Seizures |
C00000206
|
D014012 | Tinnitus |
C00000206
|
D014581 | Urticaria |
C00000206
|
D014860 | Warts |
C00000206
|